+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intracardiac Imaging Market

  • PDF Icon

    Report

  • 250 Pages
  • July 2019
  • Region: Global
  • Future Market Insights
  • ID: 5713627
There has been a significant process in the file of coronary imaging in the past decade. The non-fluoroscopic intracardiac imaging is increasingly used to guide interventional electrophysiology therapeutic procedures. This is primarily due to the advantage of real-time, direct observation and improved procedure guidance that the intracardiac imaging devices offer over the fluoroscopy methods.

Minimally invasive and transcatheter procedures are becoming more complex, this increased the demand for more detailed anatomical imaging. Devices such as intracardiac echo, thransthoracic echo, intravascular ultrasound and optical coherence tomography are some of the devices that are seeing increased use for detailed navigation procedures and to reduce radiation dose from use of angiographic fluoroscopy procedures such as intraventional valve placement, cardiac tumor ablation, coronary stent and imaging among others.

These devices are often used to form 3D and 4D images with higher details. One of the main focus of players in the intracardiac imaging market is to develop high definition images of the internal structures of the heart. Some of the key products include, iLab Ultrasound Imaging System, Vivid, Acuson X300 Ultrasound System, ViewMate Z Ultrasound Console, Acist, Polaris Imaging System and C7XR and Ilumien among others. Specialized catheters are also available for each of these systems such as, VIewFlex PLUS ICE catheter, AcuNav 8 French, AcuNav 10 French, Atlantis ICE, Ultra ICE, Ocelot, Kodama, OptiCross IVUS, and TVC Insight.

Intracardiac imaging Market: Drivers and Restraints

Increase in cardiovascular diseases, reduced risk of exposure to radiation, increase in adoption of interventional technology, rise in number of interventional cardiology procedures, favorable remburesments, increase in number of cath labs and cardiac imaging procedures are some of the factors that drive the growth of the intracardiac imaging market. However, highly regulated and stringent approval process of devices, high cost of the device and accessories, high cost of procedure are some of the factors that may hinder the growth of the intracardiac imaging market through the forecast period.

Intracardiac imaging Market: Segmentation

The global Intracardiac imaging market is segmented by product type, end users and region:

Based on the product type, the global Intracardiac imaging market is segmented into:

  • Intracardiac Echo
  • Transthoracic Echo
  • Transesophageal (TEE) imaging
  • Intravascular ultrasound (IVUS)
  • Optical coherence tomography (OCT)

Based on the end user, the global Intracardiac imaging market is segmented into:

  • Hospitals
  • Diagnostics Imaging Centers
  • Cath Labs
  • Academic and Research Institutes

Intracardiac imaging Market: Overview

The intracardiac imaging market is a relatively new market. Most of the technologies in the intracardiac imaging market are Ultrasound based. The adoption of intracardiac imaging is expected to increase significantly through the forecast period owing to favorable reimbursements, and advantages over the current interventional radiology procedures such as reduced unnecessary radiation exposure. However there are not many players in the intracardiac imaging market primarily due to the stringent approval process of devices across the world. A number of small companies are also key players in the intracardiac imaging market.

Intracardiac imaging Market: Regional Outlook

North America and Europe is expected to lead the Intracardiac imaging market owing to the rise in adoption of interventional technology, and increased research funding in the region. Increased cardiovascular diseases in the developed nations is one of the factors that drive the growth of the Intracardiac imaging market in North America and Europe Regions. Asia pacific, is expected to have a significant growth rate due to the rise in ageing population and increase in number of cardiovascular diseases, as well as rising healthcare spending and increase in number of interventional procedures in the region.

Intracardiac imaging Market: Key Players

Some of the Key players in the Intracardiac imaging market include, Boston Scientific, GE Healthcare, Siemens Healthcare, Acist Medical Systems, InfraReDx Inc, Avinger and St. Jude Medical.

The report covers exhaustive analysis on:

  • Intracardiac imaging Market Segments
  • Intracardiac imaging Market Dynamics
  • Intracardiac imaging Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Europe (Germany, Italy, France, U.K, Spain, Russia, Rest of Europe)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Malaysia, Thailand, Indonesia, Rest of South Asia)
  • Oceania (Australia & New Zealand)
  • The Middle East and Africa (GCC, S. Africa, N. Africa, Rest of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the publisher .

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations

3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/Agents/Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics

4. Global Intracardiac Imaging Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis

5. Global Intracardiac Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction/Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Intracardiac Echo
5.3.2. Transthoracic Echo
5.3.3. Transesophageal Imaging
5.3.4. Intravascular Ultrasound
5.3.5. Optical Coherence Tomography
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Intracardiac Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By End User
6.1. Introduction/Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032
6.3.1. Hospitals
6.3.2. Diagnostics Imaging Centers
6.3.3. Cath Labs
6.3.4. Academic and Research Institutes
6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Intracardiac Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia & Pacific
7.3.6. MEA
7.4. Market Attractiveness Analysis By Region

8. North America Intracardiac Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Key Takeaways

9. Latin America Intracardiac Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Mexico
9.2.1.2. Brazil
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Key Takeaways

10. Europe Intracardiac Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Spain
10.2.1.6. BENELUX
10.2.1.7. Russia
10.2.1.8. Rest of Europe
10.2.2. By Product Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Key Takeaways

11. East Asia Intracardiac Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Product Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End User
11.4. Key Takeaways

12. South Asia & Pacific Intracardiac Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. ASEAN
12.2.1.3. Australia and New Zealand
12.2.1.4. Rest of South Asia & Pacific
12.2.2. By Product Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End User
12.4. Key Takeaways

13. MEA Intracardiac Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. Turkey
13.2.1.3. South Africa
13.2.1.4. Rest of MEA
13.2.2. By Product Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By End User
13.4. Key Takeaways

14. Key Countries Intracardiac Imaging Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Product Type
14.1.2.2. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Product Type
14.2.2.2. By End User
14.3. Mexico
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Product Type
14.3.2.2. By End User
14.4. Brazil
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Product Type
14.4.2.2. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Product Type
14.5.2.2. By End User
14.6. Italy
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Product Type
14.6.2.2. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Product Type
14.7.2.2. By End User
14.8. U.K.
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Product Type
14.8.2.2. By End User
14.9. Spain
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Product Type
14.9.2.2. By End User
14.10. BENELUX
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Product Type
14.10.2.2. By End User
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Product Type
14.11.2.2. By End User
14.12. China
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Product Type
14.12.2.2. By End User
14.13. Japan
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Product Type
14.13.2.2. By End User
14.14. South Korea
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Product Type
14.14.2.2. By End User
14.15. India
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Product Type
14.15.2.2. By End User
14.16. ASEAN
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Product Type
14.16.2.2. By End User
14.17. Australia and New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Product Type
14.17.2.2. By End User
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Product Type
14.18.2.2. By End User
14.19. Turkey
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Product Type
14.19.2.2. By End User
14.20. South Africa
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Product Type
14.20.2.2. By End User

15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By End User

16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Boston Scientific
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. GE Healthcare
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Siemens Healthcare
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Acist Medical Systems
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. InfraReDx Inc
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Avinger
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Abbott
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Companies Mentioned

  • Boston Scientific
  • GE Healthcare
  • Siemens Healthcare
  • Acist Medical Systems
  • InfraReDx Inc
  • Avinger
  • St. Jude Medical